“…The number of characterized biosynthetic pathways for DKPs is relatively low relative to their known diversity (Belin et al, 2012 ; Giessen and Marahiel, 2015 ). Ten pathways that involve NRPSs have been decoded (Belin et al, 2012 ; Giessen and Marahiel, 2015 ), whereas only six have been shown to depend on CDPSs: albonoursin (Lautru et al, 2002 ), pulcherrimin (Cryle et al, 2010 ), mycocyclosin (Belin et al, 2009 ), methylated ditryptophan (Giessen et al, 2013a ), nocazines (Giessen et al, 2013b ), and, most recently bicyclomycin (Meng et al, 2017 ; Patteson et al, 2017 ). In this context, mapping the diversity of cyclodipeptides attainable by CDPSs allows the identification of new gene clusters responsible for the synthesis of DKPs with high pharmacological potential, as illustrated by the recent identification of the biosynthetic pathway of bicyclomycin, which involves a CDPS predicted to belong to the cLI/cLL-synthesizing group (Patteson et al, 2017 ).…”